Results 131 to 140 of about 89,203 (261)

On the Lymphatic Vessels in the Stroma of the Cornea

Okajimas Folia Anatomica Japonica, 1972
Imai, Masatake, Oikawa, Michi-ko
openaire   +3 more sources

Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions. [PDF]

Adv Healthc Mater
Odabasi R, Krattiger LA, Kanari M, Jacobs MA, Moser LO, Tibbitt MW, Halin C, Ehrbar M.   +7 more
europepmc   +1 more source

Lymphatic Vessels are Involved in Monosodium Urate Clearance and Resolution of Gouty Inflammation in Mice. [PDF]

J Inflamm Res
Chen S, Zhao X, Wu C, Wang CY, Yuan L, Xing L, Xu H, Liu S, Wu J, Dai J, Zhou P, Liang Q, Li N, Ruan M, Wang X.   +14 more
europepmc   +1 more source

De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer

International Journal of Cancer, EarlyView.
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley   +1 more source

Validity of Ultrasound-Guided Identification of Dilated Lymphatic Vessels to Detect Early Breast Cancer-Related Lymphedema. [PDF]

Arch Plast Surg
Hayashi A, Fuziwara T.
europepmc   +1 more source

Regeneration of Lymphatic Vessels

Annals of Surgery, 1962
C, DANESE, J M, HOWARD, R, BOWER
openaire   +3 more sources

High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy

International Journal of Cancer, EarlyView.
ABSTRACT Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine malignancy with an immunosuppressive tumor microenvironment, and current immunotherapy provides limited benefit. This highlights the need to identify microenvironmental features enabling effective immune responses.
Jiatian Fang, Zilian Wang, Hui Wang, Jianxin Xue, Kai Kang   +4 more
wiley   +1 more source

Targeting lymphatic vessels enhances bone regeneration by augmenting osteoclast activity in mouse models of amputation. [PDF]

J Clin Invest
Vishlaghi N, Ghotra TK, Mittal M, Choi JHL, Korlakunta S, Yan M, Crossley JL, Griswold-Wheeler D, Ghotbi E, Juan C, Gur-Cohen S, Mehrara B, Brown DA, Dellinger MT, Dawson LA, Levi B.   +15 more
europepmc   +1 more source

Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort Study

International Journal of Cancer, EarlyView.
ABSTRACT To improve the prediction of relapse for clinical stage I seminoma, we aimed to validate the Boormans model (incorporating tumor size, rete testis invasion, and lymphovascular invasion) against the conventional classification (tumor size > 4 cm/rete testis invasion).
Andreas Banner, Eveline Daetwyler, Stefanie Fischer, Stephanie Schöpfer‐Schwab, Karl Pemberger, Michael Scholz, Kathrin Olesch, David Oswald, Angelina Strauch, Tim Nestler, Lukas Koren‐Wagner, Robin Zeder, Clemens Mikulits, Sebastian Lenart, Christoph Seidel, Angelika Terbuch   +15 more
wiley   +1 more source

Pelvic venous disorders in women: Diagnosis and management for gynecologists

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Pelvic venous disorders (PeVD) are an underrecognized yet significant cause of chronic pelvic pain (CPP) in reproductive‐aged women, characterized by venous reflux, obstruction, or both. This clinical opinion provides a practical overview of PeVD for gynecologists, outlining its pathophysiology, common presentations, diagnostic approach, and ...
Tiffany Ni, Inbar Friedman, Jessica Smith, Brian Liu, Mary Melchior, Andrew D. Brown   +5 more
wiley   +1 more source